Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Impact of Diabetes Mellitus in Tuberculosis (TB) Patients on TB Transmission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
   Article
2. Cytokine and Chemokine mRNA Expressions afterDiagnostics (Basel, Switzerland) · 2021
   Article
3. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2017
   Article
4. QFT-Plus: a plus in variability? - Evaluation of new generation IGRA in serial testing of students with a migration background in Germany.Journal of occupational medicine and toxicology (London, England) · 2017
   Article
5. Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.Scientific reports · 2016
   Article
6. Tuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.Journal of occupational medicine and toxicology (London, England) · 2014
   Article
7. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.Clinical microbiology reviews · 2014
   Review
8. Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.PloS one · 2014
   Article
9. The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community.PloS one · 2014
   Article
10. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.Journal of clinical microbiology · 2013
    Article
11. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?PloS one · 2013
    Article
12. Serial IGRA testing of trainees in the healthcare sector in a country with low incidence for tuberculosis - a prospective cohort study.GMS hygiene and infection control · 2013
    Article
13. The effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisation.Journal of occupational medicine and toxicology (London, England) · 2013
    Article

Corrections and comments

• Comment on
  Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States.
• Erratum issued

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as